Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I G Kim

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Terapevticheskii Arkhiv|August 10, 2007
[Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]N A Tomilina, G I Storozhakov, G E Gendlin, et al.
Oncogene|March 10, 2015
PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedbackR-K Kim, Y Suh, E Hwang, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 1999
Aging process is accompanied by increase of transglutaminase CS C Park, E J Yeo, J A Han, et al.
Terapevticheskii Arkhiv|October 26, 2022
[COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic]M L Zubkin, N F Frolova, I G Kim, et al.
Oncogene|October 20, 2009
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cellsG-Y Jang, J-H Jeon, S-Y Cho, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Terapevticheskii Arkhiv|August 10, 2007
[Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]N A Tomilina, G I Storozhakov, G E Gendlin, et al.
Oncogene|March 10, 2015
PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedbackR-K Kim, Y Suh, E Hwang, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 1999
Aging process is accompanied by increase of transglutaminase CS C Park, E J Yeo, J A Han, et al.
Terapevticheskii Arkhiv|October 26, 2022
[COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic]M L Zubkin, N F Frolova, I G Kim, et al.
Oncogene|October 20, 2009
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cellsG-Y Jang, J-H Jeon, S-Y Cho, et al.
Pageof 6